Sonia Wolf: Reproductive Outcomes in Women with Sickle Cell Disease
Sonia Wolf, Consultant hematologist at Barts Health NHS Trust, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Sickle cell disease and women’s health are two things I am passionate about, and both of which are frequently neglected in medicine.
Abortion and miscarriage affect around 1 in 3 women over the course of their lives but until recently there were very few studies of these in sickle cell disease.
Therefore I am proud to present the first study in Europe of surgical abortion and surgically managed miscarriage in sickle cell disease.
My thanks to all the people who contributed to this work.”
Title: Evaluation of surgical evacuation of the uterus for abortion and management of miscarriage in patients with sickle cell disease: A multicentre UK study
Authors: Sonia Wolf, Natasha Lewis, Funmi Oyesanya, Karlene Birthwright, Tracey Masters, Andriana Andreeva
Read the Full Article on British Journal of Haematology

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC
-
Nov 18, 2026, 13:32Maria Elisa Mancuso: Next-Generation Protein Therapies in Hemophilia
-
Nov 18, 2026, 13:25Maia Meier: Advocating for Women and Girls with Bleeding Disorders
-
Nov 18, 2026, 13:19Sjoerd Fabian Koopman: Exploring Tissue Distribution of Extended Half-Life Factor IX Concentrates
-
Nov 18, 2026, 13:16Ifeanyichukwu Ifechidere: Choosing Between Clot-Based and Chromogenic Coagulation Assays